
Shattuck Labs to Showcase Research at 2025 Crohn’s and Colitis Congress: A Peek into Their Poster Presentation
Shattuck Labs to Present Innovative Research on TNF Superfamily Receptors at 2025 Crohn’s and Colitis Congress Austin, TX, and Durham, NC, February 4, 2025 – Shattuck Labs, Inc. (Shattuck), a pioneering biotechnology company, is thrilled to announce its participation in the 2025 Crohn’s and Colitis Congress, taking place in San Francisco, California, from February 6–8,…